Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on: May 21,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on:May 21,2024

Largest study of its kind reveals adjuvant chemotherapy improves overall survival for pancreatic cancer patients

byCU Anschutz Medical CampusCredit: CC0 Public DomainToday, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for panc

Updated on: January 07,2024

Largest study of its kind reveals adjuvant chemotherapy improves overall survival for pancreatic cancer patients

byCU Anschutz Medical CampusCredit: CC0 Public DomainToday, the University of Colorado Cancer Center released new research that showcases chemotherapy treatment before and after surgery for panc

Updated on:January 07,2024

Right-sided colon cancer patients have poorer survival than those with left-sided disease

by American College of SurgeonsKiller T cells surround a cancer cell. Credit: NIHORLANDO (July 23, 2018): Patients with colorectal cancer tumors on the right side may have poorer five-year surviv

Updated on: May 07,2024

Right-sided colon cancer patients have poorer survival than those with left-sided disease

by American College of SurgeonsKiller T cells surround a cancer cell. Credit: NIHORLANDO (July 23, 2018): Patients with colorectal cancer tumors on the right side may have poorer five-year surviv

Updated on:May 07,2024

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on: July 08,2024

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on:July 08,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on: July 08,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on:July 08,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on: January 16,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on:January 16,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on: February 18,2024

First-in-class targeted microRNA therapy slows cancer tumor growth

by Purdue UniversityA new therapy targets cancer cells with a modified strand of micro-RNA that naturally blocks cell division. Credit: Second Bay Studios/Purdue UniversityA new cancer therapy de

Updated on:February 18,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on: January 02,2024

Identifying the underlying causes of ovarian cancer

byCedars-Sinai Medical CenterSimon Gayther, PhD, professor of Biomedical Sciences, and Michelle Jones, PhD, a research scientist in the Center for Bioinformatics and Functional Genomics, led the

Updated on:January 02,2024

Zika virus vaccine emerges as an unlikely hero in battling brain cancer

by Duke-NUS Medical SchoolCultured human neurons infected with ZIKV-LAV. Infection in pink and cell nuclei in blue. Credit: Duke-NUS Medical SchoolScientists from Duke-NUS Medical School (Duke-NU

Updated on: March 20,2024

Zika virus vaccine emerges as an unlikely hero in battling brain cancer

by Duke-NUS Medical SchoolCultured human neurons infected with ZIKV-LAV. Infection in pink and cell nuclei in blue. Credit: Duke-NUS Medical SchoolScientists from Duke-NUS Medical School (Duke-NU

Updated on:March 20,2024

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb

Updated on: July 09,2024

Quest for better pancreatic cancer tests gains insights from survivor's data

byFlinders UniversityCA19-9 and PSA serum levels. (A) CA19-9 and PSA levels from 15th May 2017 to 27th January 2023. (B) Simple linear regression of CA19-9 and PSA at all-time points. Credit:&nb

Updated on:July 09,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on: February 24,2024

A new tool for diagnosing cancer: Platform combines structural details with molecular information about a tumor

by Harvard Medical SchoolThe Orion tool combines molecular details revealed by immunofluorescence imaging (left) with structural information gained through traditional histology staining (middle)

Updated on:February 24,2024

Two drugs reverse a key pancreatic cancer step in the lab

byUniversity of FloridaReversal of ADM by TSA in primary human acinar cultures. Primary, human acini were cultured in Matrigel on glass chamber slides for 5 days. On day 5 of culture, 500 nM of

Updated on: December 28,2023

Two drugs reverse a key pancreatic cancer step in the lab

byUniversity of FloridaReversal of ADM by TSA in primary human acinar cultures. Primary, human acini were cultured in Matrigel on glass chamber slides for 5 days. On day 5 of culture, 500 nM of

Updated on:December 28,2023